B cells exposed to enterobacterial components suppress development of experimental colitis
Background: B cells positively contribute to immunity by antigen presentation to CD4+ T cells, cytokine production, and differentiation into antibody secreting plasma cells. Accumulating evidence implies that B cells also possess immunoregulatory functions closely linked to their capability of IL‐10...
Saved in:
Published in | Inflammatory bowel diseases Vol. 18; no. 2; pp. 284 - 293 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.02.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background:
B cells positively contribute to immunity by antigen presentation to CD4+ T cells, cytokine production, and differentiation into antibody secreting plasma cells. Accumulating evidence implies that B cells also possess immunoregulatory functions closely linked to their capability of IL‐10 secretion.
Methods:
Colitis development was followed in CD4+CD25− T cell transplanted SCID mice co‐transferred with B cells exposed to an enterobacterial extract (ebx‐B cells). B and T cell cytokine expression was measured by flow cytometry and enzyme‐linked immunosorbent assay (ELISA).
Results:
We demonstrate that splenic B cells exposed to ebx produce large amounts of IL‐10 in vitro and express CD1d and CD5 previously known to be associated with regulatory B cells. In SCID mice transplanted with colitogenic CD4+CD25− T cells, co‐transfer of ebx‐B cells significantly suppressed development of colitis. Suppression was dependent on B cell‐derived IL‐10, as co‐transfer of IL‐10 knockout ebx‐B cells failed to suppress colitis. Ebx‐B cell‐mediated suppression of colitis was associated with a decrease in interferon gamma (IFN‐γ)‐producing TH1 cells and increased frequencies of Foxp3‐expressing T cells.
Conclusions:
These data demonstrate that splenic B cells exposed to enterobacterial components acquire immunosuppressive functions by which they can suppress development of experimental T cell‐mediated colitis in an IL‐10‐dependent way. (Inflamm Bowel Dis 2011;) |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1078-0998 1536-4844 |
DOI: | 10.1002/ibd.21769 |